| The effect of repetition lag on electrophysiological and haemodynamic correlates of visual object priming RN Henson, A Rylands, E Ross, P Vuilleumeir, MD Rugg Neuroimage 21 (4), 1674-1689, 2004 | 279 | 2004 |
| Pre-and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study … AJ Rylands, R Hinz, M Jones, SE Holmes, M Feldmann, G Brown, ... Biological psychiatry 72 (12), 1004-1011, 2012 | 58 | 2012 |
| Musculoskeletal features in adults with X-linked hypophosphatemia: an analysis of clinical trial and survey data MK Javaid, L Ward, R Pinedo-Villanueva, AJ Rylands, A Williams, ... The Journal of Clinical Endocrinology & Metabolism 107 (3), e1249-e1262, 2022 | 32 | 2022 |
| Carer burden in rare inherited diseases: a literature review and conceptual model K Sandilands, A Williams, AJ Rylands Orphanet Journal of Rare Diseases 17 (1), 428, 2022 | 31 | 2022 |
| A functional magnetic resonance imaging paradigm of expressed emotion in schizophrenia AJ Rylands, S McKie, R Elliott, JFW Deakin, N Tarrier The Journal of nervous and mental disease 199 (1), 25-29, 2011 | 28 | 2011 |
| Patient-reported complications, symptoms, and experiences of living with X-linked hypophosphatemia across the life-course M Cheung, AJ Rylands, A Williams, K Bailey, J Bubbear Journal of the Endocrine Society 5 (8), bvab070, 2021 | 22 | 2021 |
| Defining the characteristics of chronic hypoparathyroidism not adequately controlled on conventional therapy: consensus findings of three European delphi panels K Iqbal, N Dass, C Gip, J Vila, AJ Rylands, C Marelli Advances in therapy 36, 3007-3016, 2019 | 20 | 2019 |
| Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment P Kamenicky, K Briot, ML Brandi, M Cohen-Solal, RK Crowley, R Keen, ... RMD open 9 (1), e002676, 2023 | 19 | 2023 |
| ERP and fMRI effects of lag on priming for familiar and unfamiliar faces RN Henson, E Ross, A Rylands, P Vuilleumier, M Rugg Neuroimage 22, 624-626, 2004 | 10 | 2004 |
| Establishing equivalence of electronic clinician-reported outcome measures RLM Fuller, CW McNamara, WR Lenderking, C Edgar, A Rylands, ... Therapeutic Innovation & Regulatory Science 50 (1), 30-36, 2016 | 9 | 2016 |
| PharmacoMRI and cognitive effects of the low-trapping NMDA channel blocker AZD6765 compared with ketamine in untreated major depressive disorder JW Deakin, S Williams, D Downey, S McKie, GM Goodwin, A Rylands, ... In Abstract presented at: 28th CINP World Congress of …, 2012 | 8 | 2012 |
| Guiding principles for using clinical outcomes assessments in real-world studies: what to do when there is No regulatory guidance A Rylands, AM Rodriguez, E Molsen-David Value Outcomes Spotlight 8 (5), 2022 | 2 | 2022 |
| PRO115 a patient-centric approach to designing a mixed-methods observational study involving adolescents with X-Linked hypophosphatemia AJ Rylands, A Williams, EH Davies, SA Vincent, K Bailey Value in Health 23, S710, 2020 | 2 | 2020 |
| PF717 Quality of life (QOL), perspectives on treatment and important outcomes for multiple myeloma (MM) patients and their carers: a mixed methods evidence synthesis C Kerr, K Stubbs, N Trevor, J Galinsky, A Rylands, J Bernarde, E Boxell, ... Hemasphere 3, 313-314, 2019 | 2 | 2019 |
| A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH) V Saraff, AM Boot, A Linglart, O Semler, P Harvengt, A Williams, ... Plos one 19 (1), e0295080, 2024 | 1 | 2024 |
| Maintenance of effect of burosumab treatment and the impact of treatment interruption across a 96-week phase 3 study and 48 weeks of a phase 3b study in adults with X-linked … P Kamenicky, K Briot, ML Brandi, M Cohen-Solal, R Crowley, R Keen, ... OSTEOPOROSIS INTERNATIONAL 32 (SUPPL 1), S44-S45, 2021 | 1 | 2021 |
| Premature manifestation and accumulation of musculoskeletal-related diseases in adults with X-linked hypophosphatemia (XLH): an analysis of baseline medical history clinical … K Javaid, L Ward, R Pinedo-Villanueva, A Rylands, A Williams, K Insogna, ... JOURNAL OF BONE AND MINERAL RESEARCH 35, 289-290, 2020 | 1 | 2020 |
| Real-world evidence of the progressive and cumulative morbidity arising from X-linked hypophosphatemia (XLH) over the adult life course K Javaid, E Imel, R Pinedo-Villanueva, A Rylands, A Williams, K Insogna, ... JOURNAL OF BONE AND MINERAL RESEARCH 35, 281-282, 2020 | 1 | 2020 |
| PRO139 A patient-centric approach to cost of illness research: a case example of patient engagement to identify the hidden costs associated with blindness due to inherited … F Glen, R Sidhu, A Pulfer, A Rylands Value in Health 22, S867, 2019 | 1 | 2019 |
| Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages S Le Scouiller, C Edgar, A Rylands, C Giroudet, A Regnault, S Zarit, ... Value in Health 19 (7), A389, 2016 | 1 | 2016 |
